CareDx to Participate in Upcoming Conferences
May 22 2019 - 8:36AM
CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics
company focused on the discovery, development and commercialization
of clinically differentiated, high-value diagnostic solutions for
transplant patients, today announced that Peter Maag, Chief
Executive Officer, and Michael Bell, Chief Financial Officer, will
be participating in three upcoming conferences.
Craig-Hallum Institutional Investor Conference
in Minneapolis, MN
- Peter Maag and Mike Bell will host investor meetings on
Wednesday, May 29th
American Transplant Congress in Boston, MA
- CareDx’s leadership team will host two events on Tuesday, June
4th -- CareDx Lunch Symposium at 1:00-2:15 PM ET at the Grand
Ballroom, Sheraton Boston Hotel -- Press Conference at
4:00-4:30 PM ET at the Independence East Room, Sheraton Boston
Hotel
Jefferies 2019 Global Healthcare Conference in
New York, NY
- Peter Maag will present on Wednesday, June 5th at 9:00 AM
ET
A live audio webcast of the Jefferies 2019 Global Healthcare
Conference will be available online from the investor relations
section of the CareDx website at
http://investors.caredxinc.com or through the following link
http://wsw.com/webcast/jeff118/cdna/. The webcast replay of
the presentation will be available approximately one hour following
the conclusion of the live presentation and will be available on
the Company’s website for 90 days. Management will be hosting
one-on-one meetings for the Craig-Hallum Institutional Investor
Conference and no webcast will be available for this event.
CareDx’s events at the American Transplant Congress will not be
webcast. For more information or to RSVP for the American
Transplant Congress events please contact David Clair at
david.clair@icrinc.com.
About CareDx CareDx,
Inc., headquartered in Brisbane, California, is a molecular
diagnostics company focused on the discovery, development and
commercialization of clinically differentiated, high-value
diagnostic solutions for transplant recipients. CareDx offers
products along the pre- and post-transplant testing continuum, and
is the leading provider of genomics-based information for
transplant patients.
For more information, please visit: www.CareDx.com.
CONTACTS:Investor RelationsDavid ClairWestwicke
Partners646-277-1266david.clair@icrinc.com
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Apr 2023 to Apr 2024